Hot Topics in Hepatitis B: New Clinical Tools for Hepatitis B Management

Nov 08 2025
Convention Center: Room 146B, Level 1
8:00 AM - 9:30 AM

World Class Speakers

Scott K. Fung, MD, FRCPC, FAASLD
Presenter

Scott K. Fung, MD, FRCPC, FAASLD

University of Toronto
Richard Sterling, MD, MSc, FAASLD
Presenter

Richard Sterling, MD, MSc, FAASLD

Virginia Commonwealth University
Terry Cheuk-Fung Yip, PhD
Presenter

Terry Cheuk-Fung Yip, PhD

The Chinese University of Hong Kong
Helena Cortez-Pinto, MD, PhD, FAASLD
Presenter

Helena Cortez-Pinto, MD, PhD, FAASLD

Faculdade de Medicina, Universidade de Lisboa
Mandana Khalili, MD
Presenter

Mandana Khalili, MD

University of California, San Francisco
Robert Gish
Moderator

Robert Gish

Robert G Gish Consultants LLC

Description

Join the experts in this session to learn about highly relevant, clinical hot topic issues for hepatitis B management in 2025. Topics include: quantitative HBsAg testing in clinical practice; HCC risk calculators; noninvasive testing for hepatic fibrosis; and metabolic dysfunction-associated steatotic liver disease in patients with HBV infection. 

Journey Maps

Presentations

8:00 AM - 8:15 AM
Nov 08 2025
Washington, D.C.

Quantitative Hepatitis B Surface Antigen Testing in Clinical Practice: Different Sources of Production, Prognostic Value, and Using Results to Guide Initiation of Treatment

Scott K. Fung, MD, FRCPC, FAASLD, Presenter
Hepatitis
8:15 AM - 8:30 AM
Nov 08 2025
Washington, D.C.

Noninvasive Tests to Assess Hepatic Fibrosis in Chronic Hepatitis B: Elastography, FIB-4, APRI, and ELF Score

Richard Sterling, MD, MSc, FAASLD, Presenter
Hepatitis
8:30 AM - 8:45 AM
Nov 08 2025
Washington, D.C.

Hepatocellular Carcinoma Calculators in Clinical Practice: REACH-B, mPAGE, GALAD, and ALBI Scores, and Special Populations

Terry Cheuk-Fung Yip, PhD, Presenter
Hepatitis
8:45 AM - 9:00 AM
Nov 08 2025
Washington, D.C.

Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatitis B Infection (Met-HBV): Epidemiology, Serologic Profile, and Histology Studies

Helena Cortez-Pinto, MD, PhD, FAASLD, Presenter
Hepatitis
9:00 AM - 9:15 AM
Nov 08 2025
Washington, D.C.

Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatitis B: Clinical Management and Outcomes—Cirrhosis, Hepatocellular Carcinoma Risk, Cardiovascular Risk, and Seroclearance Rates

Mandana Khalili, MD, Presenter
Hepatitis

Objectives

  • Explain the clinical utility of quantitative HBsAg testing in the management of chronic hepatitis B infection.
  • Describe how to estimate HCC risk in patients with chronic hepatitis B infection based on risk calculators.
  • Review the assessment of hepatic fibrosis using noninvasive testing in patients with chronic hepatitis B infection.
  • Summarize the impact of MASLD/ MASH in patients with chronic hepatitis B infection in terms of clinical outcomes.
Chair

Marc G. Ghany, MD, MHSc, FAASLD

NIH/NIDDK